Precigen Inc - Asset Resilience Ratio

Latest as of December 2025: 43.18%

Precigen Inc (PGEN) has an Asset Resilience Ratio of 43.18% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PGEN liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

$67.62 Million

Cash + Short-term Investments

Total Assets

$156.62 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Precigen Inc's Asset Resilience Ratio has changed over time. See PGEN book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Precigen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PGEN stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$67.62 Million	43.18%
Total Liquid Assets	$67.62 Million	43.18%

Asset Resilience Insights

Very High Liquidity: Precigen Inc maintains exceptional liquid asset reserves at 43.18% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Precigen Inc Industry Peers by Asset Resilience Ratio

Compare Precigen Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Argen-X F:1AE	Biotechnology	25.67%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.21%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.48%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	70.49%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for Precigen Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Precigen Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	43.18%	$67.62 Million	$156.62 Million	-3.90pp
2024-12-31	47.08%	$68.39 Million	$145.27 Million	+10.48pp
2023-12-31	36.60%	$55.28 Million	$151.04 Million	+12.94pp
2022-12-31	23.66%	$51.09 Million	$215.98 Million	+3.58pp
2021-12-31	20.07%	$72.24 Million	$359.86 Million	+4.71pp
2020-12-31	15.36%	$48.33 Million	$314.59 Million	+13.33pp
2019-12-31	2.03%	$9.26 Million	$455.76 Million	-14.73pp
2018-12-31	16.77%	$120.07 Million	$716.18 Million	+15.40pp
2017-12-31	1.36%	$11.56 Million	$846.85 Million	-17.03pp
2016-12-31	18.40%	$174.60 Million	$949.07 Million	+7.96pp
2015-12-31	10.44%	$102.53 Million	$982.05 Million	-4.92pp
2014-12-31	15.36%	$88.50 Million	$576.27 Million	-11.90pp
2013-12-31	27.26%	$127.98 Million	$469.47 Million	+27.09pp
2012-12-31	0.17%	$260.00K	$151.65 Million	-0.05pp
2011-12-31	0.22%	$258.00K	$114.83 Million	--

pp = percentage points

About Precigen Inc

NASDAQ:PGEN USA Biotechnology

Market Cap

$1.44 Billion

Market Cap Rank

#7538 Global

#2142 in USA

Share Price

$4.08

Change (1 day)

-1.92%

52-Week Range

$1.28 - $5.21

All Time High

$42.80